Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions

被引：0
|
作者：
Calip, Gregory S. [1 ,2 ]
Patel, Pritesh R. [1 ]
Adimadhyam, Sruthi [1 ]
Xing, Shan [1 ]
Wu, Zhaoju [1 ]
Sweiss, Karen [1 ]
Schumock, Glen T. [1 ]
Lee, Todd A. [1 ]
Chiu, Brian C. H. [3 ]
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Univ Chicago, Chicago, IL 60637 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
34
引用
收藏
页码：18 / 19
页数：2
相关论文
共 50 条
  • [31] Genetic polymorphisms of tumor necrosis factor-α and lymphotoxin-α in Chinese patients with non-Hodgkin lymphoma
    Hui Xiao
    Kejian Zhang
    [J]. Annals of Hematology, 2011, 90 : 725 - 727
  • [32] Altered release of tumor necrosis factor and its soluble receptor in non-Hodgkin's lymphoma patients
    Rathore, VB
    Advani, SH
    Nadkarni, JJ
    [J]. CANCER DETECTION AND PREVENTION, 1999, 23 (03): : 226 - 231
  • [33] Genetic polymorphisms in the tumor necrosis factor region influence non-Hodgkin's lymphoma outcome.
    Warzocha, K
    Ribeiro, P
    Bienvenu, J
    Roy, P
    Charlot, C
    Coiffier, B
    Salles, G
    [J]. BLOOD, 1997, 90 (10) : 1501 - 1501
  • [34] Genetic polymorphisms of tumor necrosis factor-α and lymphotoxin-α in Chinese patients with non-Hodgkin lymphoma
    Xiao, Hui
    Zhang, Kejian
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (06) : 725 - 727
  • [35] Associations of Tinnitus Incidence with Use of Tumor Necrosis Factor-Alpha Inhibitors among Patients with Autoimmune Conditions
    Natarajan, Nirvikalpa
    Batts, Shelley
    Gombar, Saurabh
    Manickam, Raj
    Sagi, Varun
    Curhan, Sharon G.
    Stankovic, Konstantina M.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [36] FETAL MACROSOMY AS A RISK FACTOR FOR CHILDHOOD NON-HODGKIN LYMPHOMA: A NATIONWIDE SWEDISH COHORT STUDY
    Skalkidou, A.
    Petridou, E.
    Sergentanis, T.
    Antonopoulos, C.
    Dessypris, N.
    Svensson, T.
    Stephansson, O.
    Kieler, H.
    Smedby, K.
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S121 - S121
  • [37] Attenuated adiponectin, omentin, increased interleukin-6 and tumor necrosis factor-alpha levels with altered cognition and depression in non-Hodgkin lymphoma patients: A case-control study
    Kathpalia, Meghavi
    Mishra, Pinki
    Majid, Afsha
    Khan, Mohd. Ashif
    Sharma, Anurag
    Bhurani, Dinesh
    Nidhi
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2024, 392
  • [38] Does a Risk Management Plan Increase Safety Monitoring for the Use of Tumor Necrosis Factor-alpha Inhibitors?
    Chan, Meng-Ju
    Hsu, Chien-Ning
    Wen, Yen-Hsia
    Wang, Yu-Chin Lily
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 4 - 5
  • [39] TREATMENT OF ANKYLOSING SPONDYLITIS WITH TUMOR NECROSIS FACTOR-ALPHA INHIBITORS LOWERS THE RISK OF RENAL FUNCTION DECLINE
    Lee, S. J.
    Lee, J. S.
    Cha, U. C.
    Nam, E. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 731 - 731
  • [40] Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis
    Yildirim-Toruner, Cagri
    Kimura, Yukiko
    Rabinovich, C. Egla
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (08) : 1680 - 1681
12345